Europe Forced Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034

Coverage: By Product (Device and Accessories), Device For Product (Desktop and Portable), Accessories For Product (Filters, Nose Clip, Support Arms, and Other Accessories), Application (Asthma, COPD, and Other Applications), and End User (Hospitals and Clinics, Diagnostic Laboratories, and Other End users)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Published
  • Report Code : TIPRE00043872
  • Category : Life Sciences
  • No. of Pages : 159
  • Available Report Formats : pdf-format excel-format
  • Last update date : July 24, 2026
Europe Forced Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034
Report Date: July 24, 2026   |   Report Code: TIPRE00043872 Email: sales@theinsightpartners.com

2025 Market Size

US$

Base year value

2034 Forecast

US$

Projected by 2034

CAGR 2026-2034

5.7 %

Growth rate

Addressable Market

US$ 182,272.15 THOUSAND

(2026-2034)

The Europe Forced Oscillometry Market size is expected to reach US$ 24,847.7 Thousand by 2034 from US$ 15,193.7 Thousand in 2025. The market is estimated to record a CAGR of 5.7% from 2026 to 2034.

Executive Summary and Europe Forced Oscillometry Market Analysis:

The forced oscillometry market in Europe is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and small-airway dysfunction has heightened demand for advanced pulmonary diagnostics that go beyond traditional spirometry, particularly methods that are non-effort dependent and patient-friendly, as forced oscillometry requires only normal tidal breathing and can detect subtle lung mechanics changes even in noncooperative populations such as children and the elderly. Europe's aging population and increasing chronic illness burden have amplified the need for precise, routine respiratory monitoring, incentivizing healthcare providers to adopt newer diagnostics that improve early detection, management, and treatment personalization. Additionally, technological advancements and regulatory developments are making forced oscillometry devices more accessible, portable, and integrated with digital health systems, enabling use in clinical settings and potentially home care, while organizations such as the European Respiratory Society support standardization and clinical education. Lastly, there is growing clinical awareness and guideline recognition that oscillometry can complement or, in some cases, outperform effort-based tests for certain patient groups, which is encouraging wider adoption across hospitals and diagnostic centres throughout Europe.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Europe Forced Oscillometry Market: Strategic Insights

europe-forced-oscillometry-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Forced Oscillometry Market Segmentation Analysis:

  • By Product, the Europe Forced Oscillometry Market is segmented into Device and Accessories. The Device segment dominated the market in 2025.
  • By Device For Product, the Europe Forced Oscillometry Market is segmented into Desktop and Portable. The Desktop segment dominated the market in 2025.
  • By Accessories For Product, the Europe Forced Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment dominated the market in 2025.
  • By Application, the Europe Forced Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment dominated the market in 2025.
  • By End User, the Europe Forced Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment dominated the market in 2025.

Europe Forced Oscillometry Market Report Scope

Report Attribute Details
Market size in 2025 US$ 15,193.7 Thousand
Market Size by 2034 US$ 24,847.7 Thousand
CAGR (2026 - 2034) 5.7%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Device
  • Accessories
By Device For Product
  • Desktop
  • Portable
By Accessories For Product
  • Filters
  • Nose Clip
  • Support Arms
  • Other Accessories
By Application
  • Asthma
  • COPD
  • Other Applications
Regions and Countries Covered Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
Market leaders and key company profiles
  • COSMED Srl
  • Chest MI Inc
  • Morgan Scientific Inc
  • THORASYS Thoracic Medical Systems Inc.
  • Jaeger Medical GmbH
  • IngMar Medical
  • GANSHORN Medizin Electronic GmbH
  • Lothar Medical GmbH
  • Cognita Labs, LLC
  • RESTECH srl

Europe Forced Oscillometry Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Forced Oscillometry Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

europe-forced-oscillometry-market-cagr

Europe Forced Oscillometry Market Outlook

The effort-independent character of FOT constitutes one of its strongest competitive advantages over conventional spirometry, enabling reliable lung-function assessment in populations historically underserved by standard testing. Unlike spirometry, which demands maximal forced expiratory manoeuvres, coordinated effort, and repeated practice, FOT superimposes small pressure oscillations on normal tidal breathing for 10-20 seconds, requiring only passive cooperation. This fundamental difference translates into markedly higher feasibility rates. In a 2024 study of school-age children with bronchopulmonary dysplasia performing home-based tests, 98% completed oscillometry compared with 77% for spirometry (odds ratios 5.31-12.5 favoring oscillometry). In preschool children (3-5 years), FOT success rates range from 57% to 100% across published series, outperforming spirometry where cooperation is limited or absent. The advantage is equally pronounced in the elderly and in patients with neuromuscular weakness, cognitive impairment, or acute respiratory distress, groups in which spirometry failure rates frequently exceed 30-50%.

Clinically, this translates into broader applicability: FOT reliably detects small-airway dysfunction in 25-40% of pediatric asthma cases missed by spirometry, monitors treatment response in cystic fibrosis, and identifies early airway changes in asymptomatic smokers. Its noninvasive, quick, and repeatable nature also supports serial monitoring without patient fatigue, facilitating home or primary-care use. By removing the effort barrier that excludes millions of vulnerable patients from objective lung-function evaluation each year, FOT expands diagnostic access, improves equity in respiratory care, and meets the real-world needs of pediatric, geriatric, and critically ill populations, driving its integration into routine clinical pathways

Europe Forced Oscillometry Market Country Insights

By country, the Europe Forced Oscillometry Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2025.

In Germany, respiratory diseases such as asthma and COPD pose health challenges, with forced oscillometry emerging as a valuable tool for early detection and management due to its noninvasive nature and ability to assess small airway dysfunction during tidal breathing. The Robert Koch Institute (RKI) Journal of Health Monitoring (2023) estimates bronchial asthma prevalence at ~9%, affecting millions and contributing to emergency visits and reduced quality of life, especially in children and adults with allergic components. According to the Robert Koch Institute, the annual prevalence of COPD is 5.8% in Germany. COPD remains a leading cause of hospital admissions and mortality in older populations and affects ~6.8% of adults aged 40 and older, with higher rates in smokers and the elderly, contributing to increased demand for noninvasive monitoring tools. Forced oscillometry is particularly useful in Germany for evaluating lung mechanics in patients who struggle with spirometry, such as the elderly or those with severe symptoms, providing metrics such as resistance at 5 Hz (R5) and reactance at 5 Hz (X5) to identify abnormalities. Additionally, according to Destatis, the population aged 65 and older reached 19 million in 2024, comprising 22.3% of the total, heightening the need for oscillometry in elderly patients with reduced spirometry compliance. The European Respiratory Society's 2023 recommendations supported oscillometry integration in German pulmonary clinics for asthma-COPD overlap and interstitial lung disease evaluation.

Europe Forced Oscillometry Market Company Profiles

Some of the key players operating in the market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, IngMar Medical, GANSHORN Medizin Electronic GmbH, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Forced Oscillometry Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA